Kilitch Drugs Commences Nutraceutical Manufacturing Block at Maharashtra Plant
Kilitch Drugs (India) Limited has successfully commenced operations in its new facility, initiating the Nutraceutical Manufacturing Block of its plant. The commencement occurred on June 17, 2026.The new manufacturing block is part of a plant located in Maharashtra, India. The company confirmed that the start-up process for this specific block took place at the facility situated at 24/2/1/1, Village: Maldev, Taluka: Pen, District: Raigad.
Mukund Mehta, Managing Director of Kilitch Drugs (India) Limited, oversaw the operational commencement of this important manufacturing segment.
KILITCH Stock Price Movement
As of 2:11 PM, shares of Kilitch Drugs (India) Limited are slipping by 2.99% in live trading, currently valued at ₹179.98. Trading volume stands at 72,832 shares as the stock continues to shed value during the current market session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.